Two new studies reveal ways in which the Wnt pathway commandeers Hippo components for signaling. Azzolin et al. show how the Hippo transcription factor TAZ mediates Wnt signals, and Rosenbluh et al. show how b-catenin and YAP1 form a kinase-regulated complex with transcription factor TBX5.
Two new studies reveal ways in which the Wnt pathway commandeers Hippo components for signaling. Azzolin et al. show how the Hippo transcription factor TAZ mediates Wnt signals, and Rosenbluh et al. show how b-catenin and YAP1 form a kinase-regulated complex with transcription factor TBX5.
To ensure balanced growth and repair of tissues, signal transduction pathways such as Wnt must act in coordination with other pathways. In the case of cancer, this coordination has been corrupted, and Wnt acts at an overactive level. Two challenges for understanding cancers linked to Wnt are learning how the pathway is wired to other signals normally and identifying problems in the wiring that drive overactive Wnt signaling. The Hippo pathway is a growth-limiting, differentiation-promoting signal with known potential to link to Wnt; Wnt promotes proliferation in a broad range of tissues, and Hippo limits proliferation in an equally broad range of sites (Halder and Johnson, 2011; Hong and Guan, 2012) . In cancer, Wnt signaling is corrupted into an ''ON'' state via genetic mutations, whereas Hippo signaling is often found in an ''OFF'' state. In this issue of Cell, two provocative studies report on how these opposing pathways might crosstalk. One study presents a model that implies that the two pathways are intertwined as Wnt co-opts Hippo components for its own agenda (Azzolin et al., 2012) . The second study proposes a model in which the major second messengers, b-catenin and YAP1, combine forces to regulate a distinct subset of targets for cancer cell survival (Rosenbluh et al., 2012) .
Hippo and Wnt exert opposing effects on growth, and they do so by using similar kinds of control mechanisms for their second messenger proteins. Wnt signals to the second messenger b-catenin by preventing the destruction complex kinase GSK3-b from phosphorylating it and triggering its degradation in the cytoplasm. This allows b-catenin to enter the nucleus for regulation of gene expression. Hippo is a cadherin-based signal that does the precise opposite; it triggers phosphorylation and nuclear export of second messengers YAP1 and TAZ for degradation in the cytoplasm. Thus, while Wnt directs its second messenger, b-catenin, into the nucleus to turn gene expression on, Hippo directs its second messengers, YAP1/TAZ, out of the nucleus to turn gene expression off. As a second messenger, b-catenin is composed of a spiraling, twisted armadillo repeat array capped by unstructured N and C termini. It is not a DNA-binding protein but is built for protein interactions with a variety of transcription factors such as LEF/TCFs. YAP1 and TAZ also do not bind DNA. Instead, their array of protein interaction motifs (WW, coiled coil, SH3, and PDZ) enable association with many transcription factors, most notably the DNAbinding TEAD proteins (Hong and Guan, 2012) . The similarities extend further. Phosphorylated b-catenin, YAP1, and TAZ are each ubiquitinated and degraded by the E3 ligase b-TrCP, and they bind to one another; YAP1 and TAZ homoand heterodimerize, and each can bind to b-catenin (Murakami et al., 2005; Imajo et al., 2012) .
Both studies discover ways in which b-catenin and YAP1/TAZ crosstalk. Azzolin et al. (2012) observe that Wnt3a causes TAZ protein accumulation and increased TEAD reporter gene expression (Figure 1 ). They show that TAZ binding to GSK3-b-phosphorylated b-catenin is required for its b-TrCP-dependent ubiquitination and destruction. That is, TAZ degradation is not only similar to that for b-catenin, it is directly dependent on b-catenin. Azzolin et al. (2012) propose that, because Wnt signaling prevents b-catenin phosphorylation, it enables both second messenger proteins to accumulate, making TAZ as much a second messenger of the Wnt pathway as b-catenin. The implications are quite radical for what is currently assumed about Wnt versus Hippo. The implications for cancer are equally striking-that TAZ could be a major mediator of the proliferation and survival activities of b-catenin-active tumors. Indeed, microarray analysis of cells in which b-catenin is eliminated by small interfering RNA (siRNA) reveals that 74% of the upregulated genes are TAZ targets. This is interesting, but there are nevertheless major questions to address. For example, knockout phenotypes of YAP1, TAZ, or TEAD loci do not phenocopy loss of Wnt signaling, whereas b-catenin and LEF/TCF knockout and epistasis experiments confirm their role in the Wnt pathway in multiple model systems. Also perplexing is that, in the second study, knockdown of TAZ does not reveal a connection to b-catenin.
The second study reports a follow-up of Project Achilles, a large-scale siRNA screen for genetic weaknesses in 102 cancer cell lines (Cheung et al., 2011) . Rosenbluh et al. (2012) measure Wnt/ b-catenin activity in 85 cell lines and then search their data set for genes that are selectively important for the survival and proliferation of 19 b-catenin-active cell lines. Top-ranked genes include the second messenger YAP1, a Src-like kinase named YES1, an atypical cadherin homolog of Fat1, and two known prosurvival Hippo target genes, BIRC5 and BCL2L1. TAZ did not rank significantly, nor did the TEAD or LEF/TCF factors. Instead, the YAP1-and b-catenin-interacting DNA-binding protein TBX5 ranked highly. TBX5 belongs to a 17 member family of T-box transcription factorsnot at all related to LEF/TCFs or TEADs. The authors propose that b-cateninactive cancer specifically requires a novel b-catenin/YAP1/TBX5 complex for survival/proliferation (Figure 1) . Naturally, there are conundrums. Genome-wide chromatin immunoprecipitation studies of b-catenin in colon cancer have not identified TBX elements as a major site of occupancy (at least not yet), and because the nature of the b-catenin/YAP1/TBX5 tripartite complex is largely inferred, a careful biochemical probing will be needed to discern whether this complex is assembled as a bona fide, tripartite complex on target gene promoters. Also, the Project Achilles screen de-emphasizes the importance of redundant acting factors. TEADs and LEF/TCFs do not rank highly, most likely because redundant-acting family members are coexpressed, and in fact, the active and potent TCF-1/TCF7 was not assessed in the screen.
These caveats aside, an important discovery of this study is that the formation of the TBX5 complex and its regulation of BCL2L1 and BIRC5 depend on YES1 activity. YES1 kinase is the reason for the discovery of YAP1 18 years ago (YES1-associating protein; Sudol, 1994 ), yet amazingly, the Rosenbluh et al. (2012) study is the first to identify a functional consequence of their interaction. Dasatinib, a small-molecule inhibitor of Src kinases, prevents formation of the b-catenin/TBX5/YAP1 complex on targets and inhibits the growth of b-catenin-dependent tumors. This drug appears not to affect normal colon but strongly inhibits aberrant growth when the destruction complex is inactivated. Is the YES1 connection to Wnt and Hippo an Achilles heel specific to b-catenin-dependent cancers? If it is, then Dasatinib or selective inhibitors of YES1 are candidate drugs for Wnt-linked tumors. Why does Dasatinib inhibit only when the destruction complex is destroyed by mutation or siRNA knockdown? Do Hippo signals in normal intestine keep YES1 in check, or does the aberrant status of the destruction complex trigger activation of YES1? Also to note, Dasatinib is a broad-spectrum inhibitor of Src-like kinases and likely targets other Srcb-catenin connections, including the phosphorylation-dependent interaction with pyruvate kinase M2-an essential cofactor for transcription of WNT target genes such as cyclin D1 (Yang et al., 2011 restricts or otherwise skews the Wnt transcriptome (Figure 1 ). If it is the interplay between the two sets of second messengers that forms a gradient of cellular responsiveness, it is important to remember that Hippo signals respond to sharp discontinuities in the level of cell surface receptors on neighboring cells (Halder and Johnson, 2011) . Defining how this signature feature of Hippo influences patterns of WNT activity will be important for understanding how zones of stem cells in normal niches are established and how niches of surviving cancer stem cells are created in tumors.
